CRSP
CRISPR Therapeutics AG · Healthcare
General Counsel and Secretary James R. Kasinger sold $305K of CRISPR Therapeutics AG
Sold$304,515
$77.15Price
3,947Shares
−6%Stake
What CRSP did after the filing
- The stock from Tue, Mar 12 close, $75.30
- −26.1%
- S&P 500, same days
- −1.9%
Measured over 30 trading days, to the Apr 24 close.
Traded Mon, Mar 11. Filed Tue, Mar 12, 1:45 PM ET, during the session. Returns use the Mar 12 close and the Apr 24 close. Not investment advice.